Candida species, including C. albicans, are part of the mucosal flora of most healthy women,
and inhabit the gastrointestinal and genitourinary tracts. Under favourable conditions, they …

Human fungal infections are a historically neglected area of disease research, yet they
cause more than 1.5 million deaths every year. Our understanding of the pathophysiology of …

Candida albicans is a benign member of gut microbiota, but also causes life-threatening
disseminated infections, suggesting that this fungus commensalism has evolved with …

Successful human colonizers such as Candida pathogens have evolved distinct strategies
to survive and proliferate within the human host. These include sophisticated mechanisms to …

Candida tropicalis is a notable species of the Candida genus representing an impressive
epidemiology in tropical regions, especially in South America and Asia, where India already …

The phagocytic cells of the innate immune system are an essential first line of antimicrobial
defense, and yet Candida albicans, one of the most problematic fungal pathogens, is …

The fungus Candida albicans is a ubiquitous member of the human gut microbiota.
Hundreds or thousands of bacterial taxa reside together with this fungus in the intestine …

Candida albicans is a multimorphic commensal organism and opportunistic fungal pathogen
in humans. A morphological switch between unicellular budding yeast and multicellular …

To treat infections caused by Candida albicans, azoles, polyenes, and echinocandins are
used. However, resistance occurs against all three, so there is an urgent need for new …

Candida albicans is a major fungal pathogen of humans, accounting for 15% of nosocomial
infections with an estimated attributable mortality of 47%. C. albicans is usually a benign …